News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kremers Urban Pharmaceuticals Inc. Announces Pfizer Inc. (PFE) Lipitor(R) Settlement Agreement


11/21/2011 6:47:25 AM

PRINCETON, N.J., Nov. 18, 2011 /PRNewswire/ -- Kremers Urban Pharmaceuticals Inc. today announced that it has entered into a settlement agreement which will resolve litigation related to LipitorĀ® Tablets, 10 mg, 20 mg, 40 mg, and 80 mg, known generically as Atorvastatin Calcium tablets.

The terms of the agreement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission.

About Kremers Urban

Kremers Urban Pharmaceuticals Inc., a specialty generic drug manufacturer and subsidiary of Belgium-based UCB, is a pioneer in developing generic versions of pharmaceutical products that have a "high barrier to entry." The Company is moving to the forefront of delivering the tough solutions necessary to get complex products into the market. To learn more visit www.kremersurban.com.

For More Information Contact:

France Nivelle, Global Communications
+32 2 559 9178; france.nivelle@ucb.com

Antje Witte, Investor Relations
+32 2 559 9414; antje.witte@ucb.com

SOURCE Kremers Urban Pharmaceuticals Inc.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES